A carregar...
Overexpression and Selective Anticancer Efficacy of ENO3 in STK11 Mutant Lung Cancers
Oncogenic gain-of-function mutations are clinical biomarkers for most targeted therapies, as well as represent direct targets for drug treatment. Although loss-of-function mutations involving the tumor suppressor gene, STK11 (LKB1) are important in lung cancer progression, STK11 is not the direct ta...
Na minha lista:
| Publicado no: | Mol Cells |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Korean Society for Molecular and Cellular Biology
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6883975/ https://ncbi.nlm.nih.gov/pubmed/31697874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14348/molcells.2019.0099 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|